Leading MedTech marketplace Pipeline Medical now provides Jeuveau® by Evolus, Inc.
Pipeline Medical has announced the addition of Jeuveau® (prabotulinumtoxinA-xvfs) by Evolus (NASDAQ: EOLS) to its offerings. Jeuveau® is a popular botulinum toxin used for aesthetic improvements, particularly for frown lines. With significant market penetration since its launch in 2019, over 8,800 practices have adopted the product, achieving a reorder rate of over 70%. Pipeline Medical aims to enhance access to Jeuveau® through co-branded marketing and competitive pricing, further solidifying its position as a trusted supplier in the MedTech marketplace.
- Jeuveau® is offered at an unbeatable price point, enhancing market competitiveness.
- Pipeline Medical's growth highlights consistent product availability and significant discounts (20-40%) on medical supplies.
- The partnership with Evolus aims to increase adoption of Jeuveau® among medical providers.
- Jeuveau® has a reorder rate exceeding 70%, indicating strong product demand.
- None.
NEW BRUNSWICK, N.J., Dec. 7, 2022 /PRNewswire/ -- Pipeline Medical, a MedTech marketplace focused on supplying pharmaceuticals and medical supplies to medical professionals around the country, recently announced the addition of Jeuveau® (prabotulinumtoxinA-xvfs) by Evolus, Inc. (NASDAQ: EOLS).
Launched in 2019, Jeuveau® is a botulinum toxin type A, a prescription medicine that is injected into muscles and used in adults for a short period of time (temporary) to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines).
"Pipeline Medical was founded by aesthetic practitioners; as such, we are always looking to provide our customers with the best products in the market. Today we are thrilled to offer Jeuveau® to our customers. Jeuveau® is a top-performing toxin, dedicated strictly to aesthetics, available at an unbeatable price point," says Zachary Ducharme, CEO, of Pipeline Medical.
As a MedTech marketplace, Pipeline Medical aggregates medical supplies and pharmaceuticals from multiple manufacturers, suppliers, and distributors. Providing customers with a one-stop-shop and streamlined purchasing experience. Pipeline's consistency in product availability at low prices has led Pipeline Medical to tremendous growth in the past decade.
Pipeline Medical caters to many highly influential plastic surgeons, medical spas, dermatologists, and aesthetic practices around the country.
"At Evolus, our goal is to help providers reach the next generation of consumers with a precise product and a unique business model," said Kurt Knab, SVP of Sales at Evolus. "We look forward to partnering with Pipeline Medical to increase access to Jeuveau and expand adoption among a large and impactful group of providers." Along with the product benefits, Pipeline Medical looks forward to offering its customers Evolus' co-branded marketing model. The co-branded marketing model offers customers a wide range of advertising options, including digital ads, billboards, and most recently, streaming television advertisements, with a direct call to action to book appointments using a smartphone and QR code.
Jeuveau® is the highest-selling aesthetic product launched since 2019, with sales to more than 8,800 practices nationwide and a reorder rate of over 70 percent. These practices have administered more than 2 million treatments of Jeuveau® to date.
Pipeline Medical has gained the trust of plastic surgeons and physicians for its mastery of supply chain management and ability to offer 20
Pipeline Medical offers a wide range of products, including surgical instruments, sutures, medical supplies, surgical supplies, and pharmaceuticals. The company is constantly innovating and introducing new products that make the lives of medical providers easier.
Pipeline Medical is a single-source medical supply provider serving non-acute customers by acting as a GPO, distributor, and material manager, providing medical practitioners with significant savings of time and money.
Evolus (Nasdaq: EOLS) is a performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Its mission is to become a global, multi-product aesthetics company based on its flagship product, Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology.
Contact:
Zachary Ducharme
CEO of Pipeline Medical
zducharme@pipelinemedical.com
+1 (646) 887-7059
View original content to download multimedia:https://www.prnewswire.com/news-releases/leading-medtech-marketplace-pipeline-medical-now-provides-jeuveau-by-evolus-inc-301692550.html
SOURCE PIPELINE MEDICAL
FAQ
What is Jeuveau® and how is it used?
When was Jeuveau® launched?
How many practices have adopted Jeuveau®?
What is the reorder rate for Jeuveau®?
Who is the CEO of Pipeline Medical?
What is the stock symbol for Evolus?
What company is partnered with Pipeline Medical to offer Jeuveau®?
